Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRA | AMGN | VRTX | GILD | BMY |
| Company | Atara Biotherap | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 9.46 | 317.69 | 471.58 | 87.94 | 53.80 |
| High | 9.70 | 323.40 | 477.70 | 89.28 | 56.20 |
| Low | 8.90 | 315.65 | 468.98 | 87.74 | 53.56 |
| Last | 8.91 | 320.16 | 475.98 | 88.82 | 55.77 |
| Change | -0.67 | +4.62 | +0.90 | +0.53 | +3.11 |
| % Change | -6.99% | +1.46% | +0.19% | +0.60% | +5.91% |
| Volume | 71,300 | 2,713,400 | 1,376,000 | 5,894,500 | 18,743,900 |
| 20-Day Average Volume | 83,180 | 1,661,765 | 1,007,310 | 4,995,320 | 8,759,830 |
| Previous Close | 9.58 | 315.54 | 475.08 | 88.29 | 52.66 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.57 | 319.69 | 474.86 | 86.75 | 52.94 |
| 20-Day Raw Stochastic | 58.62% | 51.40% | 55.03% | 84.03% | 91.21% |
| 20-Day Relative Strength | 53.20% | 48.61% | 50.78% | 66.33% | 66.47% |
| Weighted Alpha | -59.92 | +16.64 | +23.85 | +19.24 | +14.40 |
| Today's Opinion | 24% Sell | 24% Buy | 56% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 24% Sell | 8% Buy | 40% Buy | 100% Buy | 72% Buy |
| Last Month's Opinion | 80% Sell | 24% Buy | 8% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.32% since 10/24/24 | +1.42% since 10/24/24 | +0.86% since 10/24/24 | +0.05% since 10/24/24 | +5.39% since 10/24/24 |
| Low | 8.30 on 10/25/24 | 310.63 on 10/30/24 | 468.47 on 10/30/24 | 86.81 on 10/29/24 | 51.81 on 10/28/24 |
| High | 9.85 on 10/30/24 | 323.40 on 10/31/24 | 480.41 on 10/25/24 | 89.74 on 10/25/24 | 56.20 on 10/31/24 |
| 1-Month | |||||
| %Chg | +9.59% since 09/30/24 | -0.64% since 09/30/24 | +2.34% since 09/30/24 | +5.94% since 09/30/24 | +7.79% since 09/30/24 |
| Low | 7.20 on 10/03/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 82.82 on 10/01/24 | 51.31 on 10/15/24 |
| High | 10.05 on 10/18/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 89.74 on 10/25/24 | 56.20 on 10/31/24 |
| 3-Month | |||||
| %Chg | -7.48% since 07/30/24 | -3.94% since 07/30/24 | -5.30% since 07/30/24 | +13.80% since 07/30/24 | +13.70% since 07/30/24 |
| Low | 6.50 on 08/16/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 10.69 on 09/05/24 | 340.89 on 08/01/24 | 510.64 on 08/01/24 | 89.74 on 10/25/24 | 56.20 on 10/31/24 |
| 6-Month | |||||
| %Chg | -48.35% since 04/30/24 | +16.87% since 04/30/24 | +21.17% since 04/30/24 | +36.23% since 04/30/24 | +26.92% since 04/30/24 |
| Low | 6.50 on 08/16/24 | 273.38 on 05/01/24 | 392.47 on 05/01/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 19.00 on 05/01/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 89.74 on 10/25/24 | 56.20 on 10/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 47,086 | 169,548,800 | 122,619,088 | 109,920,336 | 106,762,624 |
| Shares Outstanding, K | 4,915 | 537,329 | 258,102 | 1,244,992 | 2,027,395 |
| Annual Sales | 8,570,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -276,130,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 28,640,000 | 8,388,000,000 | 2,645,600,000 | 6,954,000,000 | 12,201,000,000 |
| Last Quarter Net Income | -19,050,000 | 746,000,000 | -3,593,600,000 | 1,614,000,000 | 1,680,000,000 |
| 60-Month Beta | 0.50 | 0.61 | 0.40 | 0.18 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.10 on 08/12/24 | 5.58 on 10/30/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 11/06/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 09/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.99 | 0.00 | 18.74 | 38.32 |